Ocular complications of topical, peri-ocular, and systemic corticosteroids

Current Opinion in Ophthalmology

Volumn 11, Issue 6, 2000, Pages 478-483

  Carnahan, Matthew C ^a   Goldstein, Debra A ^b  

^a EYE INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; CATARACT; DISEASE COURSE; EYE DISEASE; GLAUCOMA; HUMAN; NEUROOPHTHALMOLOGY; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; STEROID THERAPY;

CATARACT; CHOROID; CORNEAL DISEASES; DRUG ADMINISTRATION ROUTES; GLAUCOMA; GLUCOCORTICOIDS; HUMANS; RETINAL DISEASES;

EID: 0033663552     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200012000-00016     Document Type: Article

References (81)

1. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis
2. Adverse effects of inhaled corticosteroids
3. Effect of inhaled beclomethasone dipropionate and budesonide on adrenal function, shin changes and cataract formation
4. Corticosteroid-induced cataracts
5. Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine
6. A randomized prospective trial comparing cyclosporine monotherapy with triple drug therapy in renal transplantation
7. A randomized study comparing cyclosporine alone versus double and triple therapy in renal transplants
8. Use of inhaled corticosteroids and the risk of cataracts
9. Association of inhaled corticosteroid use with cataract extraction in elderly patients
10. Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids
11. Risk of cataract among users of intranasal corticosteroids
12. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma
13. Posterior subcapsular cataract formation associated with multiple lumbar epidural corticosteroid injections
14. Inhaled steroids in children: Risks versus rewards
15. Posterior subcapsular cataracts, bruising, and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide
16. Dynamic nature of posterior subcapsular cataracts
17. Cataracts and inhaled corticosteroids
18. The human lens epithelium: Morphologic and ultrastructural changes associated with steroid therapy
19. The lens: Development, proteins, metabolism and cataract
20. Use of ACTH and cortisone
21. Corticosteroids and glaucoma risk
22. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response
23. Effect of corticosteroids on intraocular pressure and fluid dynamics: I. The effect of dexamethasone in the normal eye
24. Topical corticosteroids and heredity in primary open angle glaucoma
25. Studies of the response to topical dexamethasone of glaucoma relatives
26. High myopia and primary open-angle glaucoma
27. Diabetes mellitus and primary open angle glaucoma: The XXVII Edward Jackson Memorial Lecture
28. Steroid responsiveness in connective tissue diseases
29. Systemic steroids and ocular fluid dynamics. III. The genetic nature of the ocular response and its different levels
30. Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone in the glaucomatous eye
31. Corticosteroids and intraocular pressure
32. Elevated intraocular pressure following corticosteroid eye drops
33. The cortisone test and the heredity of primary open angle glaucoma
34. Corticosteroid-induced glaucoma
35. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open angle glaucoma
36. Treatment of persistent glaucoma secondary to periocular corticosteroids
37. Inhaled corticosteroids, family history, and risk of glaucoma
38. Glaucoma secondary to topical use of steroid cream
39. Glaucoma following the application of corticosteroids to the skin of the eyelids
40. Glaucoma from topically applied steroids
41. Glucocorticoid target cells in human outflow pathway: Autopsy and surgical specimens
42. Steroids, ocular hypertension, and glaucoma
43. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes
44. Corticosteroid-induced glaucoma
45. Ophthalmologic toxicity by systemic drugs
46. Identification of a gene that causes primary open angle glaucoma
47. Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma
48. Genomic organization of the human myocilin gene (MYOC) responsible for primary open angle glaucoma (GLC1A)
49. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure
50. Increased intraocular pressure induced by repository corticosteroids
51. Biochemical quantification of triamcinolone in subconjunctival depots
52. Biochemical quantification of triamcinolone in subconjunctival depots
53. Efficacy and safety of rimexolone 1% ophthalmic solution vs 1% prednisolone acetate in the treatment of uveitis
54. Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids
55. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I
56. Change in intraocular pressure during long-term use of loteprednol etabonate
57. Calcific band keratopathy associated with the use of topical steroid-phosphate preparations
58. Corneal stromal calcification after topical steroid-phosphate therapy
59. Conjunctival necrosis following the administration of subconjunctival corticosteroid
60. Conjunctival necrosis following the administration of subconjunctival corticosteroid
61. Avoiding conjunctival necrosis after periocular depot corticosteroid injection
62. Uveitis: A Clinical Approach to Diagnosis and Management
63. Multiple embolisms in the fundus of an eye after an injection in the scalp
64. Visual loss following tonsillectomy: Possible association with injections in tonsillar fossae
65. Occlusion of the central retinal artery after retrobulbar corticosteroid injection
66. Visual loss after intranasal corticosteroid injection: Incidence, causes, and prevention
67. Retinal and choroidal microvascular embolism after intranasal corticosteroid injection
68. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion
69. Blindness as a complication of subcutaneous nasal steroid injection
70. Maculopathy: A corticosteroid side-effect
71. Central serous chorioretinopathy in endogenous hypercortisolism
72. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids
73. Systemic findings associated with central serous chorioretinopathy
74. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids
75. Familial central serous retinopathy
76. Vision loss after lumbar epidural steroid injection
77. Transient blindness following epidural analgesia
78. Bilateral retinal haemorrhages following epidural injection
79. Hormones and agents affecting hormonal mechanisms
80. Antiinflammatory agents: Section 3-corticosteroid drugs